Payment overview · 2025
General Payments
$158.46
1 reported records · 1 companies
Healthcare provider profile · identity verified
John Jabbour, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · GARFIELD HEIGHTS, OH · NPI 1487655221
Verified facts
What the public records show
CMS Open Payments records show John Jabbour, M.D. received $158.46 in general payments during 2025 across 1 reported records.
Olympus America Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Olympus America Inc. | Unresolved — no canonical attribution shown | $158.46 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $158.46 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| iTIND System Normalized: itind system |
Device | Olympus America Inc. | $158.46 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 835 | 233 |
| Amlodipine Besylate | Amlodipine Besylate | 801 | 207 |
| Gabapentin | Gabapentin | 512 | 116 |
| Omeprazole | Omeprazole | 399 | 97 |
| Lisinopril | Lisinopril | 361 | 103 |
| Metoprolol Succinate | Metoprolol Succinate | 351 | 89 |
| Levothyroxine Sodium | Levothyroxine Sodium | 350 | 98 |
| Losartan Potassium | Losartan Potassium | 342 | 88 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 339 | 100 |
| Furosemide | Furosemide | 332 | 80 |
| Metformin Hcl | Metformin Hcl | 286 | 83 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 280 | 85 |
| Potassium Chloride | Potassium Chloride | 280 | 72 |
| Pantoprazole Sodium | Pantoprazole Sodium | 273 | 76 |
| Metoprolol Tartrate | Metoprolol Tartrate | 272 | 72 |
| Tamsulosin Hcl | Tamsulosin Hcl | 270 | 66 |
| Eliquis | Apixaban | 250 | 60 |
| Tramadol Hcl | Tramadol Hcl | 240 | 78 |
| Allopurinol | Allopurinol | 223 | 51 |
| Hydralazine Hcl | Hydralazine Hcl | 178 | 44 |
| Carvedilol | Carvedilol | 169 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 168 | 50 |
| Simvastatin | Simvastatin | 168 | 49 |
| Glimepiride | Glimepiride | 158 | 39 |
| Fluticasone Propionate | Fluticasone Propionate | 143 | 43 |
| Jardiance | Empagliflozin | 132 | 34 |
| Meloxicam | Meloxicam | 132 | 29 |
| Trazodone Hcl | Trazodone Hcl | 130 | 41 |
| Clopidogrel | Clopidogrel Bisulfate | 128 | 26 |
| Famotidine | Famotidine | 125 | 27 |
| Spironolactone | Spironolactone | 123 | 37 |
| Warfarin Sodium | Warfarin Sodium | 123 | 34 |
| Metformin Hcl Er | Metformin Hcl | 122 | 28 |
| Montelukast Sodium | Montelukast Sodium | 119 | 28 |
| Glipizide | Glipizide | 118 | 29 |
| Ozempic | Semaglutide | 110 | 29 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 105 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 100 | 26 |
| Pregabalin | Pregabalin | 94 | 22 |
| Prednisone | Prednisone | 93 | 52 |
| Ibuprofen | Ibuprofen | 91 | 26 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 90 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 89 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 86 | 27 |
| Mirtazapine | Mirtazapine | 82 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 77 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 75 | 24 |
| Alprazolam | Alprazolam | 72 | 23 |
| Xarelto | Rivaroxaban | 71 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 68 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 65 | 24 |
| Doxazosin Mesylate | Doxazosin Mesylate | 64 | 15 |
| Ezetimibe | Ezetimibe | 64 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 64 | 18 |
| Farxiga | Dapagliflozin Propanediol | 63 | suppressed |
| Torsemide | Torsemide | 63 | 23 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 61 | 50 |
| Breo Ellipta | Fluticasone/Vilanterol | 61 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 60 | 18 |
| Trulicity | Dulaglutide | 60 | 11 |
| Valsartan | Valsartan | 60 | 14 |
| Januvia | Sitagliptin Phosphate | 58 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 57 | 14 |
| Bupropion Xl | Bupropion Hcl | 56 | suppressed |
| Glipizide Er | Glipizide | 53 | 12 |
| Lorazepam | Lorazepam | 53 | 20 |
| Meclizine Hcl | Meclizine Hcl | 53 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 52 | 17 |
| Sertraline Hcl | Sertraline Hcl | 52 | 16 |
| Buspirone Hcl | Buspirone Hcl | 51 | 12 |
| Lovastatin | Lovastatin | 51 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 49 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 48 | suppressed |
| Nitroglycerin | Nitroglycerin | 47 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 44 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 43 | suppressed |
| Topiramate | Topiramate | 43 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 43 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 42 | 19 |
| Celecoxib | Celecoxib | 41 | suppressed |
| Hydrocortisone | Hydrocortisone | 41 | 12 |
| Atenolol | Atenolol | 40 | 12 |
| Alendronate Sodium | Alendronate Sodium | 38 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 38 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 38 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 37 | 16 |
| Levetiracetam | Levetiracetam | 37 | suppressed |
| Naproxen | Naproxen | 37 | 14 |
| Finasteride | Finasteride | 36 | 11 |
| Methylprednisolone | Methylprednisolone | 36 | 27 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | 24 |
| Nystatin | Nystatin | 36 | 14 |
| Bupropion Hcl Sr | Bupropion Hcl | 35 | suppressed |
| Klor-Con M20 | Potassium Chloride | 35 | 11 |
| Lidocaine | Lidocaine | 34 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 34 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 33 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 33 | suppressed |
| Aripiprazole | Aripiprazole | 32 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 32 | 26 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 32 | suppressed |
| Mounjaro | Tirzepatide | 32 | 13 |
| Synthroid | Levothyroxine Sodium | 32 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 31 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 31 | suppressed |
| Ramipril | Ramipril | 30 | suppressed |
| Colchicine | Colchicine | 29 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 29 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 28 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 28 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 27 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 27 | suppressed |
| Chlorthalidone | Chlorthalidone | 26 | suppressed |
| Primidone | Primidone | 26 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Azithromycin | Azithromycin | 25 | 21 |
| Benztropine Mesylate | Benztropine Mesylate | 25 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Lamotrigine | Lamotrigine | 24 | suppressed |
| Latanoprost | Latanoprost | 24 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 24 | suppressed |
| Calcitriol | Calcitriol | 23 | suppressed |
| Digoxin | Digoxin | 22 | suppressed |
| Insulin Lispro | Insulin Lispro | 22 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 22 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 22 | 16 |
| Ondansetron Odt | Ondansetron | 22 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 21 | suppressed |
| Methocarbamol | Methocarbamol | 21 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 21 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 20 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 20 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 20 | suppressed |
| Pro Comfort Alcohol Pads | Alcohol Antiseptic Pads | 20 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 19 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Clonidine | Clonidine | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 18 | suppressed |
| Lactulose | Lactulose | 18 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Cephalexin | Cephalexin | 17 | 15 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 17 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 17 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 17 | 13 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 17 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Gavilyte-G | Peg3350/Sod Sulf,bicarb,cl/Kcl | 16 | 16 |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Tradjenta | Linagliptin | 16 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | 11 |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Zonisamide | Zonisamide | 15 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Etodolac | Etodolac | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Eszopiclone | Eszopiclone | 13 | suppressed |
| Levocarnitine | Levocarnitine | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Niacin Er | Niacin | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Clonazepam | Clonazepam | 12 | suppressed |
| Ibu | Ibuprofen | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 11 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
| Sure Comfort | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Timolol Maleate | Timolol Maleate | 11 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $158.46 · 1 records | Olympus America Inc. | iTIND System | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error